⏳ Fetching live dividend data...
Home › Calculator › ALBO Dividend Calculator 2026
Albireo Pharma, Inc. · NASDAQ
Price: $44.15 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ALBO → $27.72M in 10 years · $2,261,485.98/month
Albireo Pharma, Inc. is a biopharmaceutical company with marketed products, dedicated to researching, developing, and commercializing new treatments that modify bile acids. The company primarily targets rare liver diseases in children, as well as various other conditions affecting the liver or digestive system. Its portfolio includes Bylvay, a treatment approved for progressive familial intrahepatic cholestasis. Bylvay is also in advanced (Phase III) clinical trials for further pediatric indications such as biliary atresia and Alagille syndrome, which are both uncommon and serious childhood disorders. Additionally, Albireo offers Elobixibat, prescribed for the management of persistent constipation and other functional gastrointestinal issues. Albireo is further advancing its pipeline with A3907, currently undergoing early-stage (Phase I) clinical investigation for adult liver diseases, and A2342, a preclinical candidate designed to address adult viral and liver conditions. The company holds a licensing agreement with EA Pharma Co., Ltd. concerning the development and market rollout of Elobixibat. Albireo Pharma, Inc.'s headquarters are located in Boston, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ALBO position with:
Real after-tax yield depends on where you live and how you hold ALBO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.53% | 1.73% | $453 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.85% | 1.05% | $385 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.62% | 0.82% | $362 / yr |
| 🇬🇧 UK ISA | 0% | 4.53% | 1.73% | $453 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.13% | 1.33% | $413 / yr |
| 🇨🇦 TFSA | 0% | 4.53% | 1.73% | $453 / yr |
| 🇨🇦 CA Taxable | 25% | 3.40% | 0.60% | $340 / yr |
| 🇦🇺 Super (pension) | 15% | 3.85% | 1.05% | $385 / yr |
| 🇦🇺 AU Taxable | 30% | 3.17% | 0.37% | $317 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.34% | 0.54% | $334 / yr |
| 🇫🇷 FR Taxable | 30% | 3.17% | 0.37% | $317 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ALBO pays quarterly — 4 times per year. Next ex-div: TBD.
How ALBO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ALBO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2023-03-02 | 8,000 | $19.47 | $155.8K | ||
| D-Return | 2023-03-02 | 8,000 | $27.89 | $223.1K | ||
| D-Return | 2023-03-02 | 3,000 | $17.05 | $51.1K | ||
| U-Tender | 2023-03-02 | 56,278 | $10.00 | $562.8K | ||
| D-Return | 2023-03-02 | 5,500 | $32.53 | $178.9K | ||
| D-Return | 2023-03-02 | 4,500 | $18.54 | $83.4K | ||
| D-Return | 2023-03-02 | 8,000 | $36.87 | $295.0K | ||
| D-Return | 2023-03-02 | 5,500 | $31.22 | $171.7K | ||
| D-Return | 2023-03-02 | 16,000 | $25.86 | $413.8K | ||
| D-Return | 2023-03-02 | 5,500 | $31.22 | $171.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ALBO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Albireo Pharma, Inc. (ALBO) is currently trading at $44.15, trading near its 52-week high. The current dividend yield is 4.53% based on an annual payout of $2.00 per share.
Albireo Pharma, Inc. (ALBO) is a healthcare stock currently trading at $44.15 with a dividend yield of 4.53%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever